Anthony Kong

Has grant

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

RADIANT-BC: A multi-cohort Phase Ib/expansion cohort study of the efficacy and safety of radiosurgery with durvalumab followed by durvalumab and standard of care systemic therapy in patients with brain metastases secondary to breast cancer

Open Date: 2021-01-01

Close Date: 2026-12-01

Grant: Close

Validating the PredicTR treatment response classifier for oropharyngeal cancer (PredicTR 2)

Open Date: 2019-03-01

Close Date: 2021-02-28

Grant: Close

TWEET: A randomised phase II Trial of WEE1 inhibitor (AZD1775) with Taxane chemotherapy (paclitaxel) versus paclitaxel in head and neck squamous cell carcinoma

Open Date: 2018-12-01

Close Date:

Grant: Close

Investigating IGF -1R as a treatment target in breast cancer

Open Date: 2015-09-22

Close Date: 2018-09-21

Grant: Close

To assess the role of HER4 in relation to trastuzumab treatment and resistance in HER2 positive breast cancer

Open Date: 2013-08-12

Close Date: 2014-08-11

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Lisa Licitra

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Eliana Stanganello

Head

Johannes Gutenberg Universität Mainz

GERMANY

View details

Sally Barrington

King’s College London

UNITED KINGDOM

View details

Andrew King

King’s College London

UNITED KINGDOM

View details

Laura Feeney

The Queen's University Belfast

UNITED KINGDOM

View details

Luisa Bresadola

GERMANY

View details

Christophe Le Tourneau

Head of Early Phase Clinical Trials

Institut Curie

FRANCE

View details

Gabriella Wojewodka

King’s College London

UNITED KINGDOM

View details

Marie Morfouace

Institut Gustave Roussy

FRANCE

View details

Teresa Guerrero Urbano

Adjunct Reader

King's College London

UNITED KINGDOM

View details

Fulvia Vascotto

Head

GERMANY

View details

John Maher

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anthony Kong

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (14)

A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

Natural Language Processing to Extract Head and Neck Cancer Data From Unstructured Electronic Health Records

Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis

Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study

The Impact of Interactive MRI-Based Radiologist Review on Radiotherapy Target Volume Delineation in Head and Neck Cancer

The Therapeutic Potential of Imidazole or Quinone-Based Compounds as Radiosensitisers in Combination with Radiotherapy for the Treatment of Head and Neck Squamous Cell Carcinoma

A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.

Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16 + cancer

A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic

WEE1 Inhibitor: Clinical Development

Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma

Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient

Safety and treatment outcomes of nivolumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study.

Collaborators (12)

Lisa Licitra

Eliana Stanganello

Sally Barrington

Andrew King

Laura Feeney

Luisa Bresadola

Christophe Le Tourneau

Gabriella Wojewodka

Marie Morfouace

Teresa Guerrero Urbano

Fulvia Vascotto

John Maher

Make your next move.